<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Firebrick Pharma Limited — News on 6ix</title>
<link>https://6ix.com/company/firebrick-pharma-ltd</link>
<description>Latest news and press releases for Firebrick Pharma Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 11:11:03 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/firebrick-pharma-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683664eb78dffbe2df15d57f.webp</url>
<title>Firebrick Pharma Limited</title>
<link>https://6ix.com/company/firebrick-pharma-ltd</link>
</image>
<item>
<title>March 2026 Quarterly Activity Report & Appendix 4C</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/march-2026-quarterly-activity-report-and-appendix-4c</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/march-2026-quarterly-activity-report-and-appendix-4c</guid>
<pubDate>Tue, 21 Apr 2026 11:11:03 GMT</pubDate>
<description>March 2026 Quarterly Activity Report & Appendix 4C</description>
</item>
<item>
<title>Firebrick Secures $1.5 million via Placement</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-secures-dollar15-million-via-placement</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-secures-dollar15-million-via-placement</guid>
<pubDate>Tue, 31 Mar 2026 02:33:05 GMT</pubDate>
<description>Firebrick Secures $1.5 million via Placement</description>
</item>
<item>
<title>Trading Halt</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/trading-halt-1250</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/trading-halt-1250</guid>
<pubDate>Fri, 27 Mar 2026 02:38:05 GMT</pubDate>
<description>Trading Halt</description>
</item>
<item>
<title>Registration Agreement and Approval of Nasodine in Indonesia</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/registration-agreement-and-approval-of-nasodine-in-indonesia</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/registration-agreement-and-approval-of-nasodine-in-indonesia</guid>
<pubDate>Fri, 27 Mar 2026 02:16:05 GMT</pubDate>
<description>Registration Agreement and Approval of Nasodine in Indonesia</description>
</item>
<item>
<title>Appendix 4D & Half-Year Financial Report to 31 December 2025</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/appendix-4d-and-half-year-financial-report-to-31-december-2025-1</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/appendix-4d-and-half-year-financial-report-to-31-december-2025-1</guid>
<pubDate>Tue, 24 Feb 2026 07:13:03 GMT</pubDate>
<description>Appendix 4D & Half-Year Financial Report to 31 December 2025</description>
</item>
<item>
<title>December 2025 Quarterly Activity Report & Appendix 4C</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/december-2025-quarterly-activity-report-and-appendix-4c-3</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/december-2025-quarterly-activity-report-and-appendix-4c-3</guid>
<pubDate>Wed, 28 Jan 2026 02:39:21 GMT</pubDate>
<description>December 2025 Quarterly Activity Report & Appendix 4C</description>
</item>
<item>
<title>Nasodine Throat Spray Product Launch in Singapore</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/nasodine-throat-spray-product-launch-in-singapore</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/nasodine-throat-spray-product-launch-in-singapore</guid>
<pubDate>Wed, 21 Jan 2026 02:44:18 GMT</pubDate>
<description>Nasodine Throat Spray Product Launch in Singapore</description>
</item>
<item>
<title>Firebrick announces new product Nasodine Throat Spray</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-announces-new-product-nasodine-throat-spray</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-announces-new-product-nasodine-throat-spray</guid>
<pubDate>Thu, 30 Oct 2025 03:13:16 GMT</pubDate>
<description>Firebrick announces new product Nasodine Throat Spray</description>
</item>
<item>
<title>September 2025 Quarterly Activity Report & Appendix 4C</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/september-2025-quarterly-activity-report-and-appendix-4c-3</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/september-2025-quarterly-activity-report-and-appendix-4c-3</guid>
<pubDate>Thu, 23 Oct 2025 01:43:22 GMT</pubDate>
<description>September 2025 Quarterly Activity Report & Appendix 4C</description>
</item>
<item>
<title>Firebrick Secures Investment from Philippines Partner</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-secures-investment-from-philippines-partner</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-secures-investment-from-philippines-partner</guid>
<pubDate>Thu, 16 Oct 2025 03:14:14 GMT</pubDate>
<description>Firebrick Secures Investment from Philippines Partner</description>
</item>
<item>
<title>Firebrick receives $250,000 R&D Tax Incentive</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-receives-dollar250000-randd-tax-incentive</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-receives-dollar250000-randd-tax-incentive</guid>
<pubDate>Wed, 10 Sep 2025 02:46:10 GMT</pubDate>
<description>Firebrick receives $250,000 R&D Tax Incentive</description>
</item>
<item>
<title>Appendix 4E and Annual Report 30 June 2025</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/appendix-4e-and-annual-report-30-june-2025-10</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/appendix-4e-and-annual-report-30-june-2025-10</guid>
<pubDate>Fri, 29 Aug 2025 09:54:16 GMT</pubDate>
<description>Appendix 4E and Annual Report 30 June 2025</description>
</item>
<item>
<title>Firebrick Secures $1.4 million via Placement</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-secures-dollar14-million-via-placement</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-secures-dollar14-million-via-placement</guid>
<pubDate>Tue, 26 Aug 2025 02:30:24 GMT</pubDate>
<description>Firebrick Secures $1.4 million via Placement</description>
</item>
<item>
<title>License Agreement for Singapore, Malaysia, Brunei, Mauritius</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/license-agreement-for-singapore-malaysia-brunei-mauritius</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/license-agreement-for-singapore-malaysia-brunei-mauritius</guid>
<pubDate>Tue, 26 Aug 2025 02:29:45 GMT</pubDate>
<description>License Agreement for Singapore, Malaysia, Brunei, Mauritius</description>
</item>
<item>
<title>June 2025 Quarterly Activity Report & Appendix 4C</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/june-2025-quarterly-activity-report-and-appendix-4c-4</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/june-2025-quarterly-activity-report-and-appendix-4c-4</guid>
<pubDate>Wed, 23 Jul 2025 02:35:18 GMT</pubDate>
<description>June 2025 Quarterly Activity Report & Appendix 4C</description>
</item>
<item>
<title>Firebrick Closes Placement at $0.2 milliion</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-closes-placement-at-dollar02-milliion</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/firebrick-closes-placement-at-dollar02-milliion</guid>
<pubDate>Thu, 26 Jun 2025 03:29:18 GMT</pubDate>
<description>Firebrick Closes Placement at $0.2 milliion</description>
</item>
<item>
<title>Withdrawal of Share Placement</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/withdrawal-of-share-placement</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/withdrawal-of-share-placement</guid>
<pubDate>Fri, 06 Jun 2025 11:19:16 GMT</pubDate>
<description>Withdrawal of Share Placement</description>
</item>
<item>
<title>March 2025 Quarterly Activity Report & Appendix 4C</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/march-2025-quarterly-activity-report-and-appendix-4c-4</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/march-2025-quarterly-activity-report-and-appendix-4c-4</guid>
<pubDate>Wed, 16 Apr 2025 05:17:11 GMT</pubDate>
<description>March 2025 Quarterly Activity Report & Appendix 4C</description>
</item>
<item>
<title>FRE secures Strategic Investment from Philippines Partner</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/fre-secures-strategic-investment-from-philippines-partner</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/fre-secures-strategic-investment-from-philippines-partner</guid>
<pubDate>Tue, 04 Mar 2025 03:32:19 GMT</pubDate>
<description>FRE secures Strategic Investment from Philippines Partner</description>
</item>
<item>
<title>Appendix 4D & Half-Year Financial Report to 31 December 2024</title>
<link>https://6ix.com/company/firebrick-pharma-ltd/news/appendix-4d-and-half-year-financial-report-to-31-december-2024-2</link>
<guid isPermaLink="true">https://6ix.com/company/firebrick-pharma-ltd/news/appendix-4d-and-half-year-financial-report-to-31-december-2024-2</guid>
<pubDate>Thu, 20 Feb 2025 09:41:03 GMT</pubDate>
<description>Appendix 4D & Half-Year Financial Report to 31 December 2024</description>
</item>
</channel>
</rss>